Dow Jones Daily Bankruptcy Review featured Holland N. O'Neil, Gardere's first female chair. In the article, Ms. O'Neil discusses how her new role inspires her to lead by example. "I want to lead by example," she said. "That really transcends gender to me. I don't want to take this role on as a bully pulpit for diversity or gender issues, but it is certainly in our strategic plan."
Gardere Chief Executive Officer Steve Good added that diverse leadership is valuable to the Firm. "Ms. O'Neil is not in that position because she is a woman," he said. "She's a very talented and successful lawyer who happens to be a woman."
Subscribers can access the full article here.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”